Advertisement
  • A New Type of Drug Approval

    At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

    by Kate Yandell

  • Get Involved

    A Home Away From Home

    Ann W. Calahan started Joe's House to help cancer patients and others find places to stay when they're being treated away from home.

    by Cameron Walker

  • Cancer Researchers Offer Reasons for Optimism

    Cancer researchers and patient advocates spoke about progress against cancer at a public education forum sponsored by the American Association for Cancer Research.

    by Kevin McLaughlin

  • The Evolving Role of Patient Advocacy

    AACR's Scientist↔Survivor Program marks a milestone as patient advocates continue to shape research and policy.

    by Marci A. Landsmann

  • An Advocate’s Guide to Attending Scientific Meetings

    Two graduates of the AACR Scientist↔Survivor Program share tips for getting the most out of large scientific conferences.

    by Bob Riter and Carole Baas

  • Forward Look

    Inside the 21st Century Cures Act

    Legislation brings high hopes for cancer research.

    by Stephen Ornes

  • When Cancer Survivors Get Another Cancer

    Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.

    by Kate Yandell

  • Survivor Profile

    Putting Her Armor On

    An acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.

    by Jennifer Walker

  • The Patient Perspective

    In a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.

    by Marci A. Landsmann

  • Patient Advocates Go to Washington

    Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

    by Marci A. Landsmann